Reduction of no-reflow and reperfusion injury with the synthetic 17β-aminoestrogen compound Prolame is associated with PI3K/Akt/eNOS signaling cascade

Rapid Induction of Hypothermia by the ThermoSuit System Profoundly Reduces Infarct Size and Anatomic Zone of No Reflow Following Ischemia–Reperfusion in Rabbit and Rat Hearts

(2014) Michael J. Herring et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

A role for pericytes in coronary no-reflow

(2014) Fergus M. O'Farrell et al.   Nature Reviews Cardiology

Percutaneous Coronary Intervention to Treat Chronic Total Occlusion: Predictors of Technical Success and One-Year Clinical Outcome

(2014) Mojtaba Salarifar et al.   TEXAS HEART INSTITUTE JOURNAL

No-Reflow Phenomenon

(2013) Gennaro Galasso et al.   ANGIOLOGY

Myocardial infarction and coronary microvascular obstruction: an intimate, but complicated relationship

(2013) Gerd Heusch et al.   BASIC RESEARCH IN CARDIOLOGY

Cardioprotection—Time to Take Into Account Clinical Complexity: The Case of Antiplatelet Agents

(2013) François Roubille et al.   CARDIOVASCULAR DRUGS AND THERAPY

Two Classes of Anti-Platelet Drugs Reduce Anatomical Infarct Size in Monkey Hearts

(2013) Xi-Ming Yang et al.   CARDIOVASCULAR DRUGS AND THERAPY

Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway

(2012) Xiang-dong Li et al.   ACTA PHARMACOLOGICA SINICA

Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: a retrospective analysis

(2012) François Roubille et al.   BASIC RESEARCH IN CARDIOLOGY

Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts

(2012) Xi-Ming Yang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Cardioprotection: chances and challenges of its translation to the clinic

(2012) Gerd Heusch   LANCET

Clopidogrel improves endothelial function and NO bioavailability by sensitizing adenylyl cyclase in rats with congestive heart failure

(2011) Andreas Schäfer et al.   BASIC RESEARCH IN CARDIOLOGY

Estrogen Signaling and Cardiovascular Disease

(2011) Elizabeth Murphy   CIRCULATION RESEARCH

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

(2011) Glenn N. Levine et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Management of the no-reflow phenomenon

(2011) Michelle J. Butler et al.   PHARMACOLOGY & THERAPEUTICS

The antithrombotic effect of the aminoestrogen prolame (N-(3-hydroxy-1,3,5(10)-estratrien-17B-YL)-3-hydroxypropylamine) is linked to an increase in nitric oxide production by platelets and endothelial cells

(2009) Georgina González et al.   ATHEROSCLEROSIS

Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve

(2009) Gerd Heusch   BASIC RESEARCH IN CARDIOLOGY

Coronary Microembolization

(2009) Gerd Heusch et al.   CIRCULATION

Effect of High-Dose Intracoronary Adenosine Administration During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

(2009) Marieke L. Fokkema et al.   Circulation-Cardiovascular Interventions

Myocardial No-Reflow in Humans

(2009) Giampaolo Niccoli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ischemic Postconditioning in Pigs

(2008) Andreas Skyschally et al.   CIRCULATION RESEARCH

Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion

(2007) Sharon L. Hale et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY